Allergan Aesthetics, an AbbVie Company · 2 months ago
2026 QTAS Bioanalytical Intern (Master's)
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines. The QTAS team is looking for a motivated intern to support bioanalytical development, focusing on ex-vivo stimulation processes and ligand binding assays.
BeautyManufacturingPharmaceuticalWellness
Responsibilities
Perform ex-vivo stimulation of human blood
Perform ligand binding assay e.g. MSD, Olink etc, on human plasma samples
Possible to perform human PBMC immunophenotyping by flow cytometry
Qualification
Required
Currently enrolled in university, pursuing a Master's degree in Biology, Biochemistry, Immunology, Pharmacology, or related fields
Must be enrolled in university for at least one semester following the internship
Experience handling human blood samples
Proficiency in data analysis and summary
Strong skills in MS Office applications are essential
Good communication skills, quick learner, motivated, and team player
Preferred
Expected graduation date between December 2026 – June 2027
Experience with bench work in immunoassays such as ELISA and MSD
Familiarity with FACS assay is a plus
Experience with Prism, and scripting in Python or R is preferred
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
Allergan Aesthetics, an AbbVie Company
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products.
H1B Sponsorship
Allergan Aesthetics, an AbbVie Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)
2023 (1)
2022 (16)
2021 (14)
2020 (5)
Funding
Current Stage
Late StageLeadership Team
Recent News
2025-12-04
Company data provided by crunchbase